Who owns Alexion Pharmaceuticals?

Key details on Alexion Pharmaceuticals (Ticker: ALXN)

Who owns Alexion Pharmaceuticals?

Is ALXN a good stock to own? Find out who bought Alexion Pharmaceuticals, who sold Alexion Pharmaceuticals (ALXN) stock, and who holds a large position in Alexion Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 24.23M $3.79B June 30, 2014
FMR 20.10M $3.33B Sept. 30, 2014
T. Rowe Price Associates 17.30M $2.70B June 30, 2014
Vanguard 10.28M $1.70B Sept. 30, 2014
Jennison Associates 8.38M $1.39B Sept. 30, 2014
STATE STREET CORPORATION 8.12M $1.35B Sept. 30, 2014
JPMORGAN CHASE & CO 6.77M $1.12B Sept. 30, 2014
Sands Capital Management 5.31M $880.75M Sept. 30, 2014
Wells Fargo & Company 5.23M $817.69M June 30, 2014
BlackRock Institutional Trust Company, N.A. 5.07M $841.02M Sept. 30, 2014
Columbia Wanger Asset Management 3.71M $344.78M March 31, 2012
BlackRock Fund Advisors 3.37M $558.64M Sept. 30, 2014
WINSLOW CAPITAL MANAGEMENT INC /MN 3.37M $558.33M Sept. 30, 2014
Inves 3.35M $555.31M Sept. 30, 2014
American Century Companies 3.26M $539.86M Sept. 30, 2014
Ameriprise Financial 3.17M $315.07M June 30, 2012
VIKING GLOBAL INVESTORS 2.88M $382.30M Dec. 31, 2013